Back
Dyne Therapeutics Stock Price Chart
Sponsored
DYN
Sponsored
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.
Buy
66
DYN
Dyne Therapeutics
Last Price:
30.93
Seasonality Move:
38.02%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.- The current trend is relatively stagnant and DYN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Dyne Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.58 | Buy |
20-day SMA: | 30.81 | Buy |
50-day SMA: | 32.62 | Buy |
200-day SMA: | 32.06 | Buy |
8-day EMA: | 30.24 | Buy |
20-day EMA: | 30.74 | Buy |
50-day EMA: | 32.95 | Buy |
200-day EMA: | 30.83 | Buy |
Dyne Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.99 | Sell |
Relative Strength Index (14 RSI): | 60.64 | Buy |
Chaikin Money Flow: | 1192325 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.99 - 33.51) | Buy |
Bollinger Bands (100): | (31.49 - 42.59) | Sell |
Dyne Therapeutics Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Dyne Therapeutics Stock
Is Dyne Therapeutics Stock a Buy?
- Dyne Therapeutics share price is 34.14 while DYN 8-day simple moving average is 29.58, which is a Buy signal.
- The stock price of DYN is 34.14 while Dyne Therapeutics 20-day SMA is 30.81, which makes it a Buy.
- Dyne Therapeutics 50-day simple moving average is 32.62 while DYN share price is 34.14, making it a Buy technically.
- DYN stock price is 34.14 and Dyne Therapeutics 200-day simple moving average is 32.06, creating a Buy signal.
DYN Technical Analysis vs Fundamental Analysis
Buy
66
Dyne Therapeutics (DYN)
is a Buy
Is Dyne Therapeutics a Buy or a Sell?
-
Dyne Therapeutics stock is rated a Buy
The current Dyne Therapeutics [DYN] share price is $34.14. The Score for DYN is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
Dyne Therapeutics Stock Info
Market Cap:
3.43B
Price in USD:
34.14
Share Volume:
2.22M
Dyne Therapeutics 52-Week Range
52-Week High:
47.45
52-Week Low:
9.26
Buy
66
Dyne Therapeutics (DYN)
is a Buy
Dyne Therapeutics Share Price Forecast
-
What is the Dyne Therapeutics stock price today?
The Dyne Therapeutics stock price is 34.14 USD today. -
Will DYN stock go up or go down?
Dyne Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Dyne Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Dyne Therapeutics is not overvalued.
Is Dyne Therapeutics Stock a Buy?
- Dyne Therapeutics share price is 34.14 while DYN 8-day exponential moving average is 30.24, which is a Buy signal.
- The stock price of DYN is 34.14 while Dyne Therapeutics 20-day EMA is 30.74, which makes it a Buy.
- Dyne Therapeutics 50-day exponential moving average is 32.95 while DYN share price is 34.14, making it a Buy technically.
- DYN stock price is 34.14 and Dyne Therapeutics 200-day simple moving average is 30.83, creating a Buy signal.
Fundamental Analysis of Dyne Therapeutics
Is Dyne Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.54 per share, and an increase next year of $0.08 per share.
Technical Analysis of Dyne Therapeutics
Should I short Dyne Therapeutics stock?
- DYN Moving Average Covergence Divergence (MACD) indicator is -0.99, suggesting Dyne Therapeutics is a Sell
- Dyne Therapeutics Relative Strength Index (RSI) is 60.64, which suggest Dyne Therapeutics is overbought
- The Bollinger Bands (25) for Dyne Therapeutics is (28.99 - 33.51), which suggest Dyne Therapeutics is a Sell
- The Bollinger Bands (100) for Dyne Therapeutics is (31.49 - 42.59), which suggest Dyne Therapeutics is a Sell
* Dyne Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.